Status:
RECRUITING
A Novel Integrative Non-invasive Embryo Selection Approach for IVF Based on MK-RS Analysis
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Reproductive Issues
Subfertility
Eligibility:
All Genders
Phase:
NA
Brief Summary
During assisted reproductive technology treatment, embryo selection is an important process that may affect the clinical pregnancy rate. Many assisted reproductive technology units over the world have...
Detailed Description
Our study will include two phases. In Phase I (a retrospective study), archived data will be collected to train the CNN-enhanced MK with RS method on embryo selection, leading to the integrated approa...
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing IVF/ ICSI treatment
- Patients receiving the first, second or third IVF/ICSI treatment cycle
- Patients and their partners willing to sign the informed consent agreement
- Patients having at least three normal fertilised embryos on the day of the fertilization check
- Consecutive women undergoing IVF treatment
- Patients planning to use a time-lapse incubator for embryo culture
Exclusion Criteria:
- Day one human embryos with blur imaging
- Large obstructions in the embryo area
- More than half of the embryo area is blocked by the well or degeneration
- Patients with more than half of the embryos without sufficient spent culture medium for RS analysis
- Patients with known genetic diseases
Key Trial Info
Start Date :
July 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT05896709
Start Date
July 17 2023
End Date
December 1 2026
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong
Hong Kong, Hong Kong